Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
about
Molecular switches of the κ opioid receptor triggered by 6'-GNTI and 5'-GNTI.Can tapentadol cause a false-positive urine drug screen result for amphetamine?Symptom management in the older adult: 2015 updateSuccessful use of stellate ganglion block and a new centrally acting analgesic with dual mode of action in a resistant temporomandibular joint painUse of Opioids and Sedatives at End-of-Life.Clinical management of pain in advanced lung cancer.Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.Addictions in pain clinics and pain treatment.Opioid-induced constipation: challenges and therapeutic opportunities.Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy.Risks associated with drug treatments for kidney stones.Acute abdomen in a patient with cancer pain on oxycodone.NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with μ-Opioid Agonist Activity.Antinociceptive Effect of 3-(2,3-Dimethoxyphenyl)-1-(5-methylfuran-2-yl)prop-2-en-1-one in Mice Models of Induced Nociception.Tapentadol extended-release: a recent addition to our analgesic armamentarium.[Interdisciplinary guidance for pain management in nursing home residents].Opioid-induced constipation.
P2860
Q27302413-896B66C5-2460-470C-8231-A06355D6134AQ28649899-51A426CD-CFE0-4DAC-B2F0-3BBC6FFE6D22Q30374202-D63B1D08-3A67-493E-AA25-8E8225468720Q33691651-386AD7DD-B4F6-4ED0-B375-284FFF7D91B1Q34032871-D4404E69-5704-46CA-9472-FC7E434B6275Q36327481-9EA71BEB-EC05-4193-A416-5729620050F7Q37200907-F5B6A8DD-0721-4F19-A4AB-C65AC5B9D447Q37832750-B29D9806-182F-472A-9636-1E6AD9431869Q37846099-920DB0F3-F7B1-43CE-BECB-D2AC245615EFQ38187698-C3667EF1-AE7E-45AD-B349-79601D2858ABQ38645658-2AA6CE0E-932B-4A12-A6AE-BF4CD03D4F4AQ38909992-2ADEBBAA-BB47-4E01-8B2C-DB84FBD5B66DQ39735009-8E493A01-CEA3-4C5E-B270-9C6A21C5B4F4Q51839931-1A395243-71AF-4EB1-9601-99A941A3AB2FQ52304304-FB46EA22-9FAE-4206-B451-5B6259ED9585Q52887142-04E6DE77-6276-4C16-BF14-82EEFB6BC5A3Q54262333-246BB2CF-4503-4780-A9CB-871171DDD1DE
P2860
Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Review of the effect of opioid ...... dol, a step toward a solution?
@ast
Review of the effect of opioid ...... dol, a step toward a solution?
@en
Review of the effect of opioid ...... dol, a step toward a solution?
@nl
type
label
Review of the effect of opioid ...... dol, a step toward a solution?
@ast
Review of the effect of opioid ...... dol, a step toward a solution?
@en
Review of the effect of opioid ...... dol, a step toward a solution?
@nl
prefLabel
Review of the effect of opioid ...... dol, a step toward a solution?
@ast
Review of the effect of opioid ...... dol, a step toward a solution?
@en
Review of the effect of opioid ...... dol, a step toward a solution?
@nl
P921
P1476
Review of the effect of opioid ...... dol, a step toward a solution?
@en
P2093
Keith A Candiotti
Melvin C Gitlin
P304
P356
10.1185/03007995.2010.483941
P407
P577
2010-07-01T00:00:00Z